Ali et al. showed that sodium butyrate reduced LPS-induced apoptosis and inflammation by inhibiting the NF-kB and caspase/bax signaling pathways, suggesting that sodium butyrate can be used as a therapeutic agent for mastitis [28]. This evidence concerns the gene NFKB1 and mastitis.